Chinese Molecular Diagnostics Firm GenomePrecision Raises Series B Round

Beijing GenomePrecision Technology Co., a Chinese precision medicine firm focused on molecular diagnostics, has raised a nearly RMB100 million (US$14.75 million) series B financing round from a group of investors, according to a statement released on the WeChat official account of one investor on Monday. These investors include Chinese investment firm Dynamic Balance Investment, venture […]

Chinese Molecular Diagnostics Firm GenomePrecision Raises Series B Round comes originally from China Money Network. All Rights Reserved.

Read the original article: China Money Network